SPARC/osteonectin, an endogenous mechanism for targeting albumin to the blood-cerebrospinal fluid interface during brain development
SA Liddelow, KM Dziegielewska, K Mollgard, TN Phoenix, S Temple, JL VandeBerg, NR Saunders
European Journal of Neuroscience | WILEY | Published : 2011
Awarded by European Union
Awarded by NIH/NINDS
The research leading to these results has received funding from the National Health and Medical Research Council (Australia) as part of an agreement with the European Union Seventh Framework Program (FP7/2007-2013) under grant agreement No. HEALTH-F2-2009-241778. Additional funding was made available by the Robert J. Kleberg, Jr and Helen C. Kleberg Foundation (USA). We acknowledge the research infrastructure provided by the Texas Biomedical Research Institute. S. A. Liddelow, K. M. Dziegielewska and N. R. Saunders are members of the Neurobid Consortium, funded by the Seventh Framework Program (EU) and NHMRC. K. Mollgard is an adviser to the Neurobid Consortium. The project was also supported by funding from the Regenerative Research Foundation and Grant Number NS033529 from NIH/NINDS to S. Temple.